Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION 2023-06-12
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 12, 2023 2023-06-12
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 2023-06-06
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES ON KN026 IN COMBINATION WITH KN046 FOR PRESENTATION AT 2023 ASCO ANNUAL MEETING 2023-06-06
Next Day Disclosure Return 2023-05-23
INSIDE INFORMATION ANNOUNCEMENT UPDATES IN RELATION TO A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED SQ NSCLC 2023-05-19
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, JUNE 12, 2023 2023-05-09
NOTICE OF ANNUAL GENERAL MEETING 2023-05-09
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; (4) PROPOSED ADOPTION OF THE FIFTH AMENDED AND RESTATED ARTICLES OF ASSOCIATION; AND (5) NOTICE OF ANNUAL GENERAL MEETING 2023-05-09
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 2023-05-05

7 8 9 10 11 12 13